Discovering the unknown: How does in silico process development change PD scientists’ work?
Jeanne Linke Northrop, BioPharm International
Nora Ketterer, Manager, Modeling Services, Cytiva
Top Tips for Successful Development of Antibody Chromatography Processes
Jeanne Linke Northrop, BioPharm International
Jakob Liderfelt, Global Product Manager, Monoclonal Antibody Polishing, Cytiva
Top challenges in recombinant protein purification process development
Jeanne Linke Northrop, BioPharm International
Emma Lind, Product Manager, Chromatography Resins, Cytiva
Optimizing your Cell Culture Process to Improve Productivity
Jeanne Linke Northrop, Biopharm International
Mary Szorik, Senior Manager of Analytical Services, Cytiva
Alice Elwood, Analytical Services Product Manager, Cytiva
Chromatography for the Diversified Antibody Pipeline
Jeanne Linke Northrop, BioPharm International
Eva Heldin, Section Manager of Antibody Application, R&D, Cytiva
Current Techniques and Challenges Presented in Scaling Between Bioreactors
Jeanne Linke Northrop, BioPharm International
Andreas Castan, Strategic Technology Partnerships Leader, Cytiva
What's in Your Media? How Costly is Variability of Cell Culture Media to Your Manufacturing Process?
Megan Manzano, BioPharm International
Christopher Woolstenhulme, Lead Analytical Scientist of Manufacturing Sciences, Cytiva
Tools and Methodologies for Smarter Downstream Process Development
Gayle S. Putrich, BioPharm International
John Scibetta, Advanced Chromatography Specialist, Cytiva
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Megan Manzano, BioPharm International
Greg Farlow, RNA/DNA Product Specialist, Cytiva
Using Mechanistic Modeling in Process Development for Advanced Therapeutics
Felicity Thomas, Pharmaceutical Technology Europe
Peter Guterstam, Product Manager, Advanced Therapeutics Downstream Solutions, Cytiva
Nick Whitelock, Commercial Modeling Specialist, Cytiva
Analytical Considerations for Successful Upstream Process Development with Spivey and Lane
Chris Spivey, BioPharm International
Dr. Gregory Lane, Bristol Myers Squibb
Implementation of inline conditioning to advance process intensification
Filippo Bertoli, Senior Associate Scientist, Janssen
Séamus McHugh, Operations Manager, Janssen
Joanne Sheehy, Staff Manufacturing Process Specialist, Janssen
Sean Coomey Principal Process Engineer, Janssen
Heather Nagle, Staff Technical Operations Engineer, Janssen
Insider Recommendations for Getting Started with Mechanistic Modeling of Chromatography
Nick Whitelock, Sales Specialist, Cytiva
Andreas Castan, PhD, Strategic Technology Partnerships Leader of Business Development & Strategy, Cytiva
Dr. Oliver Hardick, Business Leader in the BioProcess group at Cytiva
Rita Peters, Editorial Director of BioPharm International
Rita Peters, Editorial Director of BioPharm International
Günter Jagschies, Strategic Customer Relations Leader, Cytiva
Aaron Noyes, Head of Downstream Processing at Codiak BioSciences
Hybrid Bioprocessing
Andrew Sinclair, President and Founder of BioPharm Services
Improvements in Protein A Chromatography
Glen Bolton, Scientific Director, Amgen
Speed and Flexibility Are Dual Goals for Biopharma Operations
Rita Peters, Editorial Director of BioPharm International
Adopting Single-Use Systems
Parrish Galliher, Chief Technology Officer Upstream at Cytiva
The Evolution of the Role of CMOs in Bioprocessing
Eric Langer, President and Managing Partner at BioPlan Associates
Phil Lester, Co-Organizer of the HTPD Conference
The Future of QbD, Part 1
Dr. Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi
The Future of QbD, Part 2
Dr. Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi
Mechanistic Modeling: Does it Have a Future in Process Development?
Dr. Arne Staby, Fellow, Novo Nordisk
Continuous Chromatography: Trends, Definitions and Approaches
Dr. Karol Lacki, Customer Collaborations Leader, Cytiva
The Role of HIC in Biotech
Professor Alois Jungbauer, Department of Biotechnology, BOKU
Günter Jagschies, Cytiva
Jeff Carter, Cytiva
Bioprocessing Trends and Technologies at INTERPHEX 2016
Rita Peters, Editorial Director of BioPharm International
CMOs Embrace New Technology
Eric Langer, BioPlan Associates